MRI Drug Debate Sparks Libel Suit Against Scientist

“In a joint report, the London Sunday Times and ProPublica, an American investigative journalism enterprise, yesterday detailed a libel lawsuit against Henrik Thomsen, a Danish clinician who is among those that alerted patients and regulators to potential risks of a drug called Omniscan that is administered to people receiving MRIs in order to improve the images …” (more)

[John Travis, Science Insider, 21 December]


Leave a Reply